Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 249

1.

Efficiency of delivery observed treatment in hemodialysis patients: the example of the native vitamin D therapy.

Delanaye P, Cavalier E, Fafin C, Dubois BE, Krzesinski JM, Moranne O.

J Nephrol. 2015 Apr 10. [Epub ahead of print]

PMID:
25857297
2.

Two novel mutations of the CLDN16 gene cause familial hypomagnesaemia with hypercalciuria and nephrocalcinosis.

Hanssen O, Castermans E, Bovy C, Weekers L, Erpicum P, Dubois B, Bours V, Krzesinski JM, Jouret F.

Clin Kidney J. 2014 Jun;7(3):282-5. doi: 10.1093/ckj/sfu019. Epub 2014 Mar 16.

3.

[Fixed dose combination perindopril-indapamide-amlodipine (Triplixam) for the treatment of arterial hypertension].

Scheen AJ, Lancellotti P, Krzesinski JM.

Rev Med Liege. 2014 Oct;69(10):565-70. French.

PMID:
25796752
4.

Impact of stopping vitamin K antagonist therapy on concentrations of dephospho-uncarboxylated Matrix Gla protein.

Delanaye P, Dubois BE, Lukas P, Peters P, Krzesinski JM, Pottel H, Cavalier E.

Clin Chem Lab Med. 2015 Mar 9. pii: /j/cclm.ahead-of-print/cclm-2015-0073/cclm-2015-0073.xml. doi: 10.1515/cclm-2015-0073. [Epub ahead of print] No abstract available.

PMID:
25781548
5.

Activation of the calcium-sensing receptor before renal ischemia/reperfusion exacerbates kidney injury.

Weekers L, de Tullio P, Bovy C, Poma L, Marée R, Bonvoisin C, Defraigne JO, Krzesinski JM, Jouret F.

Am J Transl Res. 2015 Jan 19;7(1):128-38. eCollection 2015.

6.

[Native vitamin D in dialysis patients].

Delanaye P, Bouquegneau A, Krzesinski JM, Cavalier É, Jean G, Urena-Torres P, Souberbielle JC.

Nephrol Ther. 2015 Feb;11(1):5-15. doi: 10.1016/j.nephro.2014.10.004. Epub 2015 Jan 14. French.

PMID:
25597001
7.

Biomarkers and physiopathology in the cardiorenal syndrome.

Bouquegneau A, Krzesinski JM, Delanaye P, Cavalier E.

Clin Chim Acta. 2015 Mar 30;443:100-7. doi: 10.1016/j.cca.2014.10.041. Epub 2014 Oct 31.

PMID:
25444738
8.

Clinical and biological determinants of sclerostin plasma concentration in hemodialysis patients.

Delanaye P, Krzesinski JM, Warling X, Moonen M, Smelten N, Médart L, Bruyère O, Reginster JY, Pottel H, Cavalier E.

Nephron Clin Pract. 2014;128(1-2):127-34. doi: 10.1159/000366449. Epub 2014 Nov 4.

PMID:
25377055
9.

[The role of mesenchymal stromal cells in solid organ transplantation].

Delens L, Jouret F, Detry O, Beguin Y, Krzesinski JM.

Rev Med Suisse. 2014 Aug 27;10(439):1538, 1540-3. French.

PMID:
25272670
10.

Dephosphorylated-uncarboxylated Matrix Gla protein concentration is predictive of vitamin K status and is correlated with vascular calcification in a cohort of hemodialysis patients.

Delanaye P, Krzesinski JM, Warling X, Moonen M, Smelten N, Médart L, Pottel H, Cavalier E.

BMC Nephrol. 2014 Sep 4;15:145. doi: 10.1186/1471-2369-15-145.

11.

[Management of arterial hypertension in the elderly].

Xhignesse P, Saint-Remy A, Krzesinski JM.

Rev Med Liege. 2014 May-Jun;69(5-6):294-300. Review. French.

PMID:
25065235
12.

[How to manage chronic kidney disease in the elderly?].

Krzesinski JM, Delanaye P.

Rev Med Liege. 2014 May-Jun;69(5-6):287-93. Review. French.

PMID:
25065234
13.

Inter-method variability in bone alkaline phosphatase measurement: clinical impact on the management of dialysis patients.

Cavalier E, Souberbielle JC, Gadisseur R, Dubois B, Krzesinski JM, Delanaye P.

Clin Biochem. 2014 Sep;47(13-14):1227-30. doi: 10.1016/j.clinbiochem.2014.04.007. Epub 2014 Apr 15.

PMID:
24743048
14.

Mesenchymal stromal cell therapy in conditions of renal ischaemia/reperfusion.

Erpicum P, Detry O, Weekers L, Bonvoisin C, Lechanteur C, Briquet A, Beguin Y, Krzesinski JM, Jouret F.

Nephrol Dial Transplant. 2014 Aug;29(8):1487-93. doi: 10.1093/ndt/gft538. Epub 2014 Feb 9. Review.

PMID:
24516234
15.

Detection of decreased glomerular filtration rate in intensive care units: serum cystatin C versus serum creatinine.

Delanaye P, Cavalier E, Morel J, Mehdi M, Maillard N, Claisse G, Lambermont B, Dubois BE, Damas P, Krzesinski JM, Lautrette A, Mariat C.

BMC Nephrol. 2014 Jan 13;15:9. doi: 10.1186/1471-2369-15-9.

16.

[Role of AMP-activated protein kinase in renal ischemic preconditioning].

Erpicum P, Krzesinski JM, Jouret F.

Nephrol Ther. 2014 Feb;10(1):17-24. doi: 10.1016/j.nephro.2013.10.006. Epub 2013 Dec 30. Review. French.

PMID:
24387947
17.

[Evaluation of glomerular filtration rate in 2014].

Delanaye P, Krzesinski JM.

Rev Med Liege. 2014;69 Spec No:47-52. French.

PMID:
25796798
18.

[New guidelines for hypertension management in 2013].

Xhignesse P, Krzesinski JM.

Rev Med Liege. 2013 Oct;68(10):511-20. French.

PMID:
24298725
19.

Modification of Diet in Renal Disease versus Chronic Kidney Disease Epidemiology Collaboration equation to estimate glomerular filtration rate in obese patients.

Bouquegneau A, Vidal-Petiot E, Vrtovsnik F, Cavalier E, Rorive M, Krzesinski JM, Delanaye P, Flamant M.

Nephrol Dial Transplant. 2013 Nov;28 Suppl 4:iv122-30. doi: 10.1093/ndt/gft329. Epub 2013 Sep 11.

PMID:
24026245
20.

[Orthostatic hypotension: 2nd part. Epidemiology, complications and treatments].

Tyberghein M, Philips JC, Krzesinski JM, Scheen AJ.

Rev Med Liege. 2013 Apr;68(4):163-70. French.

PMID:
23755705
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk